Douglas K. Kyle-Hogarth
Expertise in
15
conditions

Dr. Douglas K. Kyle-Hogarth

Pulmonary Medicine | Intensive Care Medicine
5758 S Maryland Ave, 
Chicago, IL 
Offers Telehealth
Expertise in
15
conditions
5758 S Maryland Ave, 
Chicago, IL 

Overview

D. Kyle Hogarth, MD, is an expert in pulmonary diseases. He is also involved with the minimally invasive diagnosis, management, staging and treatment of lung cancer through bronchoscopy. Dr. Hogarth was one of the first doctors in Illinois to work with the superDimension system — an electromagnetic navigation system that uses 3-D imaging technology to detect and biopsy nodules and masses. He was the first physician in the region to utilize the Auris Monarch platform, a robotic bronchoscope that allows deeper access to the lung without surgery. He uses endobronchial ultrasound to biopsy lymph nodes, place stents in cancerous airways, and perform all other minimally invasive techniques to help patients with lung cancer. He sees patients in clinic on Fridays.

Dr. Kyle-Hogarth is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Lung Nodules, Emphysema, Alpha-1 Antitrypsin Deficiency (AATD), Endoscopy, and Advanced Bronchoscopy.

Dr. Kyle-Hogarth is board certified in Critical Care Medicine and Pulmonary Medicine. He is actively involved in clinical research, co-authoring 95 peer reviewed articles and participating in 3 clinical trials.

Residency

University of Chicago Medicine

Specialties

Pulmonary Medicine
Intensive Care Medicine

Licenses

Internal Medicine in IL

Board Certifications

Critical Care Medicine
Pulmonary Medicine

Fellowships

University of Chicago Medicine

Hospital Affiliations

Northwest Health - Porter
Ingalls Memorial Hospital
The University Of Chicago Medical Center
Uchicago Medicine Northwest Indiana
UChicago Medicine Faculty Physicians

Languages Spoken

English

Gender

Male

Awards

Dr. Hogarth was the first physician in Illinois to perform bronchial thermoplasty, a FDA-approved technique to treat severe asthma. He has done the most cases in the US and has authored numerous publications on this topic.
Dr. Hogarth was the first physician in Illinois to perform Bronchoscopic Lung Volume Reduction (bLVR) for severe emphysema using the Zephyr valve.
In 2007 and 2011, he received the Department of Medicine’s Outstanding Junior Faculty Clinical Service Award and in 2013 and 2014 the Department of Medicine’s Outstanding Clinical Service Award. In addition to his clinical and research work, Dr. Hogarth is on the editorial board for Chest — The Journal of the American College of Chest Physicians and the Proceedings of the American Thoracic Society. He is also a manuscript reviewer for European Respiratory Journal, Lung Cancer, Respiratory Research and 12 other journals
Dr. Hogarth is the past president of the Society for Advanced Bronchoscopy.

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

UChicago Medicine Physicians
5758 S Maryland Ave, Chicago, IL 60637

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease - Alpha-1 Biomarker Research Consortium (A1BC)
Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease - Alpha-1 Biomarker Research Consortium (A1BC)
Enrollment Status: Active_not_recruiting
Publish Date: January 16, 2026
A Phase 3/4 Study to Evaluate the Safety, Immunogenicity, and Effects on the Alpha1-Proteinase Inhibitor (A1PI) Levels in Epithelial Lining Fluid Following Glassia Therapy in A1PI-Deficient Subjects
A Phase 3/4 Study to Evaluate the Safety, Immunogenicity, and Effects on the Alpha1-Proteinase Inhibitor (A1PI) Levels in Epithelial Lining Fluid Following Glassia Therapy in A1PI-Deficient Subjects
Enrollment Status: Completed
Publish Date: October 14, 2021
Intervention Type: Biological
Study Phase: Phase 3
Multicenter, Prospective, OL, Single-arm Clinical Study of Safety & Feasibility of Using Navigational Bronchoscopy to Perform Interstitial PD Therapy Using Photofrin® as Treatment in Subjects With Unresectable Solid Tumor in Peripheral Lung
Multicenter, Prospective, OL, Single-arm Clinical Study of Safety & Feasibility of Using Navigational Bronchoscopy to Perform Interstitial PD Therapy Using Photofrin® as Treatment in Subjects With Unresectable Solid Tumor in Peripheral Lung
Enrollment Status: Completed
Publish Date: March 04, 2020
Intervention Type: Device, Drug
Study Phase: Phase 1
View 2 Less Clinical Trials

95 Total Publications

Sequential Bilateral Bronchoscopic Lung Volume Reduction for Residual Hyperinflation Following Successful Index Procedure in Pulmonary Emphysema: A Multicenter Study.
Sequential Bilateral Bronchoscopic Lung Volume Reduction for Residual Hyperinflation Following Successful Index Procedure in Pulmonary Emphysema: A Multicenter Study.
Journal: Journal of bronchology & interventional pulmonology
Published: July 25, 2025
Similar Doctors
Expertise in
21
conditions
Dr. Mary E. Strek
Pulmonary Medicine
Expertise in
21
conditions
Dr. Mary E. Strek
Pulmonary Medicine
Referral may be required

UChicago Medicine Duchossois Center For Advanced Medicine - Hyde Park

5758 S. Maryland Ave., 
Chicago, IL 
 (0.1 miles away)
888-824-0200
Languages Spoken:
English, French, Turkish
See accepted insurances
Accepting New Patients
Offers Telehealth

Mary Strek is a Pulmonary Medicine provider practicing medicine in Chicago, Illinois. Dr. Strek is highly rated in 21 conditions, according to our data. Her clinical expertise encompasses Acute Interstitial Pneumonia, Interstitial Lung Disease, Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis, and Lung Transplant. Dr. Strek is board certified in Internal Medicine Pulmonary Disease and Practicing Since1990. Dr. Strek is currently accepting new patients.

Expertise in
9
conditions
Dr. Ayodeji O. Adegunsoye
Pulmonary Medicine
Expertise in
9
conditions
Dr. Ayodeji O. Adegunsoye
Pulmonary Medicine
Referral may be required
Before you request

UChicago Medicine Duchossois Center For Advanced Medicine - Hyde Park

5758 S. Maryland Ave., 
Chicago, IL 
 (0.1 miles away)
888-824-0200
Languages Spoken:
English, Yoruba
See accepted insurances
Accepting New Patients
Offers Telehealth

Ayodeji Adegunsoye is a Pulmonary Medicine provider practicing medicine in Chicago, Illinois. Dr. Adegunsoye is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Acute Interstitial Pneumonia, Interstitial Lung Disease, Pulmonary Fibrosis, Hypersensitivity Pneumonitis, and Lung Transplant. Dr. Adegunsoye is board certified in Pulmonary Disease, 2017, Internal Medicine, Practicing Since, and Critical Care Medicine. Dr. Adegunsoye is currently accepting new patients.

Expertise in
11
conditions
Dr. Rade Tomic
Pulmonary Medicine
Expertise in
11
conditions
Dr. Rade Tomic
Pulmonary Medicine
Referral may be required

UChicago Medicine Duchossois Center For Advanced Medicine - Hyde Park

5758 S. Maryland Ave., 
Chicago, IL 
 (0.1 miles away)
888-824-0200
Languages Spoken:
English, Croatian, Serbo Croatian, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Rade Tomic is a Pulmonary Medicine provider practicing medicine in Chicago, Illinois. Dr. Tomic is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Acute Interstitial Pneumonia, Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Lung Transplant, and Thrombectomy. Dr. Tomic is board certified in Pulmonary Disease Critical Care Medicine. Dr. Tomic is currently accepting new patients.

Frequently Asked Questions about Dr. Douglas K. Kyle-Hogarth

How do I make an appointment with Dr. Douglas K. Kyle-Hogarth?

You can book an appointment with Dr. Douglas K. Kyle-Hogarth by calling their office at 773-702-9660. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Douglas K. Kyle-Hogarth a top-rated expert for Lung Nodules?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Douglas K. Kyle-Hogarth is classified as an Elite expert for Lung Nodules, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Douglas K. Kyle-Hogarth specialize in?

While Dr. Douglas K. Kyle-Hogarth is a Pulmonary Medicine, they have specific expertise in Lung Nodules, Emphysema, and Alpha-1 Antitrypsin Deficiency (AATD). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pulmonary Medicine.

Does Dr. Douglas K. Kyle-Hogarth participate in research or clinical trials?

Yes. Dr. Douglas K. Kyle-Hogarth has published 95 articles and abstracts on conditions like Lung Nodules. You can view a list of Dr. Douglas K. Kyle-Hogarth's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Douglas K. Kyle-Hogarth accept my insurance?

Dr. Douglas K. Kyle-Hogarth accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 773-702-9660 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kyle-Hogarth's expertise for a condition
ConditionClose
View All 10 Advanced Conditions
View All 37 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile